{"id":"https://openalex.org/W4381544074","doi":"https://doi.org/10.1358/dot.2000.36.7.589153","title":"Pharmacological treatment of Alzheimer disease: From psychotropic drugs and cholinesterase inhibitors to pharmacogenomics","display_name":"Pharmacological treatment of Alzheimer disease: From psychotropic drugs and cholinesterase inhibitors to pharmacogenomics","publication_year":2000,"publication_date":"2000-01-01","ids":{"openalex":"https://openalex.org/W4381544074","doi":"https://doi.org/10.1358/dot.2000.36.7.589153","mag":"24086560","pmid":"https://pubmed.ncbi.nlm.nih.gov/12861345"},"language":"en","primary_location":{"id":"doi:10.1358/dot.2000.36.7.589153","doi":"https://doi.org/10.1358/dot.2000.36.7.589153","is_oa":false,"landing_page_url":"https://doi.org/10.1358/dot.2000.36.7.589153","pdf_url":null,"source":{"id":"https://openalex.org/S202615048","display_name":"Drugs of today","issn_l":"0025-7656","issn":["0025-7656","1699-3993","1699-4019"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4360969288","host_organization_name":"Prous Science","host_organization_lineage":["https://openalex.org/P4360969288"],"host_organization_lineage_names":["Prous Science"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs of Today","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004538565","display_name":"Ram\u00f3n Cacabelos","orcid":"https://orcid.org/0000-0002-0554-4037","observed_orcids":["https://orcid.org/0000-0002-0554-4037"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cacabelos, R.","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113580570","display_name":"Ant\u00f3n \u00c1lvarez","orcid":"https://orcid.org/0000-0002-2827-1748","observed_orcids":["https://orcid.org/0000-0002-2827-1748"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alvarez, A.","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061950927","display_name":"Valter Lombardi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lombardi, V.","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"et al.","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"et al.","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.5607,"has_fulltext":false,"cited_by_count":81,"citation_normalized_percentile":{"value":0.90490362,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"36","issue":"7","first_page":"415","last_page":"415"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.0044999998062849045,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.002400000113993883,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9959999918937683},{"id":"https://openalex.org/keywords/drug-therapy","display_name":"pharmacotherapy","score":0.8980000019073486},{"id":"https://openalex.org/keywords/cholinesterase-inhibitors","display_name":"cholinesterase inhibitors","score":0.9940000176429749},{"id":"https://openalex.org/keywords/muscarinic-receptor-agonists","display_name":"muscarinic agonists","score":0.8759999871253967},{"id":"https://openalex.org/keywords/psychotropic-drugs","display_name":"psychotropic drugs","score":0.8960000276565552},{"id":"https://openalex.org/keywords/pharmacogenomics","display_name":"pharmacogenomics","score":0.8679999709129333},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.7200000286102295},{"id":"https://openalex.org/keywords/amyloid-beta","display_name":"amyloid-beta","score":0.6579999923706055},{"id":"https://openalex.org/keywords/tau-hyperphosphorylation","display_name":"tau hyperphosphorylation","score":0.9399999976158142},{"id":"https://openalex.org/keywords/neuroinflammation","display_name":"neuroinflammation","score":0.9039999842643738},{"id":"https://openalex.org/keywords/excitotoxicity","display_name":"excitotoxicity","score":0.7559999823570251},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.765999972820282},{"id":"https://openalex.org/keywords/stem-cell-therapy","display_name":"stem cell therapy","score":0.6549999713897705},{"id":"https://openalex.org/keywords/gene-therapy","display_name":"gene therapy","score":0.9599999785423279},{"id":"https://openalex.org/keywords/antisense-oligonucleotides","display_name":"antisense oligonucleotides","score":0.996999979019165},{"id":"https://openalex.org/keywords/neurodegeneration","display_name":"neurodegeneration","score":0.5849999785423279},{"id":"https://openalex.org/keywords/nootropics","display_name":"nootropic drugs","score":0.5709999799728394}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9431682825088501},{"id":"https://openalex.org/C170734499","wikidata":"https://www.wikidata.org/wiki/Q1152227","display_name":"Pharmacogenomics","level":2,"score":0.8014227151870728},{"id":"https://openalex.org/C31896038","wikidata":"https://www.wikidata.org/wiki/Q415635","display_name":"Cholinesterase","level":2,"score":0.6638436913490295},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.6232411861419678},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5754107236862183},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.32924893498420715},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2624056339263916},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1358/dot.2000.36.7.589153","doi":"https://doi.org/10.1358/dot.2000.36.7.589153","is_oa":false,"landing_page_url":"https://doi.org/10.1358/dot.2000.36.7.589153","pdf_url":null,"source":{"id":"https://openalex.org/S202615048","display_name":"Drugs of today","issn_l":"0025-7656","issn":["0025-7656","1699-3993","1699-4019"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4360969288","host_organization_name":"Prous Science","host_organization_lineage":["https://openalex.org/P4360969288"],"host_organization_lineage_names":["Prous Science"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs of Today","raw_type":"journal-article"},{"id":"pmid:12861345","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12861345","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs of today (Barcelona, Spain : 1998)","raw_type":"Journal Article"},{"id":"mag:24086560","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12861345","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":2,"referenced_works":["https://openalex.org/W1797080633","https://openalex.org/W2104777676"],"related_works":["https://openalex.org/W2071300482","https://openalex.org/W1830024","https://openalex.org/W1969793439","https://openalex.org/W2317583919","https://openalex.org/W2186563374","https://openalex.org/W2506341650","https://openalex.org/W4388315934","https://openalex.org/W2105586329","https://openalex.org/W2003109394","https://openalex.org/W2757601767"],"abstract_inverted_index":{"For":[0],"the":[1,5,9,19,32,43,53,67,96,103,109,116,121,134,144,166,327,373,394,399,426],"past":[2,54],"20":[3],"years":[4],"scientific":[6],"community":[7],"and":[8,218,241,311,348,365,379,405],"pharmaceutical":[10,97],"industry":[11,98],"have":[12,37,62,338],"been":[13,63,339],"searching":[14],"for":[15,46,60,186,265,272,287,354,372,415,435],"treatments":[16],"to":[17,108,114,124,160,173,179,224,300,315,432],"neutralize":[18],"devastating":[20],"effects":[21],"of":[22,35,95,111,118,147,155,226,258,375,383,387,401,425],"Alzheimer":[23],"disease":[24],"(AD).":[25],"During":[26,52],"this":[27],"period":[28],"important":[29],"changes":[30],"in":[31,70,84,88,139,158,190,197,215,267,309,351,418,440],"etiopathogenic":[33,312],"concept":[34],"AD":[36,48,61,148,156,167,198,273,322,355],"occurred":[38],"and,":[39],"as":[40,81],"a":[41,125,152,412],"consequence,":[42],"pharmacological":[44,145],"approach":[45],"treating":[47],"has":[49,99],"also":[50,100],"changed.":[51],"2":[55],"decades":[56],"only":[57],"3":[58],"drugs":[59,76,163,176,286,308],"formally":[64],"approved":[65],"by":[66],"FDA,":[68],"although":[69],"many":[71],"countries":[72],"there":[73],"are":[74,78,262],"several":[75,307],"which":[77,106],"currently":[79],"used":[80],"neuroprotecting":[82,280],"agents":[83],"dementia":[85],"alone":[86],"or":[87],"combination":[89,310,345],"with":[90,278,284,292,297,321,341,390,398,442],"cholinesterase":[91,112],"inhibitors.":[92],"The":[93,192,381],"interest":[94],"shifted":[101],"from":[102],"cholinergic":[104,298,329],"hypothesis":[105],"led":[107],"development":[110,353,417],"inhibitors":[113],"enhance":[115],"bioavailability":[117],"acetylcholine":[119],"at":[120,428],"synaptic":[122,229],"cleft":[123],"more":[126],"\"molecular":[127],"approach\"":[128],"based":[129],"on":[130,133,151],"new":[131,175],"data":[132],"pathogenic":[135,195,260],"events":[136,171,196,206,212,232,243,261],"underlying":[137],"neurodegeneration":[138],"AD.":[140,191,268],"In":[141],"our":[142],"opinion,":[143],"treatment":[146,266,274,277,283,291,296,305,313,374],"should":[149],"rely":[150],"better":[153],"understanding":[154],"etiopathogenesis":[157],"order":[159],"use":[161],"current":[162],"that":[164,337,408],"protect":[165],"brain":[168,219,377],"against":[169],"deleterious":[170],"and/or":[172,181,253],"develop":[174],"specifically":[177],"designed":[178,314],"inhibit":[180],"regulate":[182,316],"those":[183],"factors":[184,318],"responsible":[185],"premature":[187],"neuronal":[188,209,391],"death":[189],"most":[193],"relevant":[194],"can":[199],"be":[200],"classified":[201],"into":[202],"main":[203],"categories:":[204],"primary":[205,252],"(genetic":[207],"factors,":[208],"apoptosis),":[210],"secondary":[211],"(beta-amyloid":[213],"deposition":[214],"senile":[216],"plaques":[217],"vessels,":[220],"neurofibrillary":[221],"tangles":[222],"due":[223],"hyperphosphorylation":[225],"tau":[227],"proteins,":[228],"loss),":[230],"tertiary":[231],"(neurotransmitter":[233],"deficits,":[234,303],"neurotrophic":[235],"alterations,":[236],"neuroimmune":[237],"dysfunction,":[238],"neuroinflammatory":[239],"reactions)":[240],"quaternary":[242],"(excitotoxic":[244],"reactions,":[245],"calcium":[246],"homeostasis":[247],"miscarriage,":[248],"free":[249],"radical":[250],"formation,":[251],"reactive":[254],"cerebrovascular":[255],"dysfunction).":[256],"All":[257],"these":[259],"potential":[263],"targets":[264],"Potential":[269],"therapeutic":[270],"strategies":[271,336,347],"include":[275],"palliative":[276],"nonspecific":[279],"agents,":[281],"symptomatic":[282],"psychotropic":[285],"noncognitive":[288],"symptoms,":[289],"cognitive":[290],"cognition":[293],"enhancers,":[294],"substitutive":[295],"enhancers":[299,330],"improve":[301],"memory":[302],"multifactorial":[304],"using":[306],"molecular":[317],"potentially":[319],"associated":[320,389],"pathogenesis.":[323],"This":[324],"review":[325],"discusses":[326],"conventional":[328],"(cholinesterase":[331],"inhibitors,":[332],"muscarinic":[333],"agonists),":[334],"noncholinergic":[335],"developed":[340],"other":[342],"compounds,":[343],"novel":[344,370],"drug":[346,352,416],"future":[349],"trends":[350],"treatment.":[356],"Stem-cell":[357],"activation,":[358],"genetically":[359],"manipulated":[360],"cell":[361],"transplantation,":[362],"gene":[363],"therapy":[364],"antisense":[366],"oligonucleotide":[367],"technology":[368],"constitute":[369],"approaches":[371],"gene-related":[376],"damage":[378],"neuroregeneration.":[380],"identification":[382],"an":[384],"increasing":[385],"number":[386],"genes":[388],"dysfunction":[392],"along":[393],"human":[395],"genome":[396],"together":[397],"influence":[400],"specific":[402],"allelic":[403],"associations":[404],"polymorphisms":[406],"indicate":[407],"pharmacogenomics":[409],"will":[410,430],"become":[411],"preferential":[413],"procedure":[414],"polygenic":[419],"complex":[420],"disorders.":[421],"Furthermore,":[422],"genetic":[423],"screening":[424],"population":[427],"risk":[429],"help":[431],"identify":[433],"candidates":[434],"prevention":[436],"among":[437],"first-degree":[438],"relatives":[439],"families":[441],"transgenerational":[443],"dementia.":[444]},"counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":5},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-06-22T00:00:00"}